Gilan Pharmaceutical Company
Gilaranco Pharmaceutical and Cosmetic Co. is an Iranian manufacturer founded in 1986 that specializes in medicated soaps, shampoos and other dermatological products. Its factory is reported in Rasht Industrial City, Gilan Province, with a central office in Tehran. The company should not be conflated with Sobhan Darou or Caspian Tamin Pharmaceutical Co.; its ownership, financial scale, capacity and export activity remain unverified.
Market position
Gilaranco appears to occupy a specialized position in Iran’s dermatological-product segment, with medicated soaps, shampoos and topical treatments forming the core of its reported range. It should be assessed separately from Sobhan Darou and Caspian Tamin Pharmaceutical Co., both Gilan-based pharmaceutical companies with distinct corporate histories and broader or different product portfolios.
Operations & footprint
Products and services
Gilan Pharmaceutical Company is treated as a provisional pharmaceutical manufacturing profile connected to medicine production, healthcare supply, pharmacy distribution, hospital demand, raw-material procurement, and regulated pharmaceutical manufacturing in Gilan Province. Its exact product categories, current operating company, and market status require further verification.
Operations and assets
Operating assets include a factory in Rasht Industrial City, Gilan Province, and a central office in Tehran.
Geographic footprint
Manufacturing is reported in Rasht Industrial City, Gilan Province, while the central office is in Tehran. No specific export markets or international sales activity were verified.
Competitors and peer set
Sobhan Darou and Caspian Tamin Pharmaceutical Co. are distinct Gilan-based pharmaceutical companies, but the supplied evidence does not establish a direct competitive relationship.
Commercial and investment relevance
Gilan Pharmaceutical is relevant only as a provisional profile until the exact legal entity is confirmed. If verified, it may help investors assess pharmaceutical manufacturing capacity in Gilan, regional healthcare supply, medicine distribution, raw-material import dependence, and technology gaps in smaller drug producers. Due diligence should prioritize legal-name confirmation, registry status, factory location, product registrations, ownership, GMP certification, operating continuity, ticker status, and whether the intended company is distinct from Sobhan, Caspian Tamin, or other Rasht-based pharmaceutical producers. The company’s focused portfolio may be relevant to purchasers and suppliers of dermatological treatments, medicated personal-care products and topical pharmaceutical formulations. Its commercial role is more clearly defined by this specialization than by scale, as no verified revenue, output or export data were provided.
Constraints, risk & compliance
Key risks and constraints
Key diligence gaps include current ownership, production capacity, product-registration status, quality certifications, revenue and export activity. These gaps limit assessment of operating scale and commercial continuity.
Sanctions and compliance considerations
No direct sanctions information was identified. As an Iranian pharmaceutical-sector company, counterparties should conduct transaction-specific sanctions, export-control, payment and end-user compliance reviews.
Need more than a public profile?
Ask Hormuz to investigate, verify or act locally around Gilan Pharmaceutical Company. Tell us exactly what you need.
Connected Intelligence
Relevant geography, industry, market and execution context for this profile.
Frequently asked questions
Direct answers to the questions most likely to arise when reviewing this profile.
What does Gilaranco Pharmaceutical and Cosmetic Co. produce?
The company specializes in medicated soaps, shampoos and other dermatological products. Reported products include topical treatments, clobetasol ointment and lidocaine/prilocaine cream.
Where is Gilaranco located?
Its factory is reported in Rasht Industrial City, Gilan Province, Iran. Its central office is reported in Tehran.
Is Gilaranco Pharmaceutical and Cosmetic Co. publicly listed?
No public listing or ticker symbol was identified in the supplied evidence.
What sanctions considerations apply to Gilaranco?
No direct sanctions information was identified. Counterparties should conduct transaction-specific sanctions, export-control, payment and end-user compliance reviews.